Meningeal metastasis patients with EGFR G724S who develop resistance to osimertinib benefit from the addition of afatinib

Detalles Bibliográficos
Autores principales: Li, Yibin, Lin, Yantang, Wu, Jingxun, Ye, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653111/
https://www.ncbi.nlm.nih.gov/pubmed/33209641
http://dx.doi.org/10.21037/tlcr-20-847
_version_ 1783607834309558272
author Li, Yibin
Lin, Yantang
Wu, Jingxun
Ye, Feng
author_facet Li, Yibin
Lin, Yantang
Wu, Jingxun
Ye, Feng
author_sort Li, Yibin
collection PubMed
description
format Online
Article
Text
id pubmed-7653111
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-76531112020-11-17 Meningeal metastasis patients with EGFR G724S who develop resistance to osimertinib benefit from the addition of afatinib Li, Yibin Lin, Yantang Wu, Jingxun Ye, Feng Transl Lung Cancer Res Letter to the Editor AME Publishing Company 2020-10 /pmc/articles/PMC7653111/ /pubmed/33209641 http://dx.doi.org/10.21037/tlcr-20-847 Text en 2020 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Letter to the Editor
Li, Yibin
Lin, Yantang
Wu, Jingxun
Ye, Feng
Meningeal metastasis patients with EGFR G724S who develop resistance to osimertinib benefit from the addition of afatinib
title Meningeal metastasis patients with EGFR G724S who develop resistance to osimertinib benefit from the addition of afatinib
title_full Meningeal metastasis patients with EGFR G724S who develop resistance to osimertinib benefit from the addition of afatinib
title_fullStr Meningeal metastasis patients with EGFR G724S who develop resistance to osimertinib benefit from the addition of afatinib
title_full_unstemmed Meningeal metastasis patients with EGFR G724S who develop resistance to osimertinib benefit from the addition of afatinib
title_short Meningeal metastasis patients with EGFR G724S who develop resistance to osimertinib benefit from the addition of afatinib
title_sort meningeal metastasis patients with egfr g724s who develop resistance to osimertinib benefit from the addition of afatinib
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653111/
https://www.ncbi.nlm.nih.gov/pubmed/33209641
http://dx.doi.org/10.21037/tlcr-20-847
work_keys_str_mv AT liyibin meningealmetastasispatientswithegfrg724swhodevelopresistancetoosimertinibbenefitfromtheadditionofafatinib
AT linyantang meningealmetastasispatientswithegfrg724swhodevelopresistancetoosimertinibbenefitfromtheadditionofafatinib
AT wujingxun meningealmetastasispatientswithegfrg724swhodevelopresistancetoosimertinibbenefitfromtheadditionofafatinib
AT yefeng meningealmetastasispatientswithegfrg724swhodevelopresistancetoosimertinibbenefitfromtheadditionofafatinib

Ejemplares similares